Sebia enters into agreement with Sanofi to develop multiple myeloma diagnostic test
Sebia will develop the test and act as worldwide supplier
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Jan 20
Sebia will develop the test and act as worldwide supplier
08 Jan 20
Mobidiag is harnessing the power of its Novodiag platform to develop a fast, simple and reliable syndromic assay…
The Phase II contract follows a Phase I contract that supported development of initial proof-of-concept data for PathMAP…
08 Jan 20
Eargo is a medical device company dedicated to improving the quality of life of people with hearing loss
08 Jan 20
IceCure Medical is an Israeli medical device company that develops and markets an advanced liquid-nitrogen-based cryoablation therapy for…
08 Jan 20
Allurion Technologies is dedicated to helping people realize their full potential with innovative, scalable and trusted experiences
08 Jan 20
HeartMate 3 is a CE Mark and FDA approved commercial Left Ventricular Assist Device (LVAD), and uses Full…
08 Jan 20
PRELUDE-BTK clinical trial will be conducted by eight investigators from New Zealand, Austria, Germany and Poland, and includes…
08 Jan 20
Aerobika OPEP and VersaPAP devices offer tandem therapy for lung expansion and airway clearance
08 Jan 20
Oncologists can use the NeXT Dx test to identify potential therapies and clinical trial options for cancer patients